Korean drugmakers rebound domestically

Published: 2013-06-04 06:58:00

Updated: 2013-06-04 06:58:00

Korean drugmakers are bouncing back fast in the domestic market on the back of recovering profit margin thanks to their active marketing activities and less spending on promotion, figures showed Monday.

According to data released by Yakup.com, a pharmaceutical information portal, the local pha...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK